Hirotaka Watase

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY® compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials

Tsutomu Takeuchi, Yukihiro Chino, Masafumi Kawanishi et al. · Arthritis Research & Therapy · 2023 · 34 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Role for enhanced faecal excretion of bile acid in hydroxysteroid sulfotransferase-mediated protection against lithocholic acid-induced liver toxicity

Masaaki Miyata, Hirotaka Watase, Wataru Hori et al. · Xenobiotica · 2006 · 24 citations

Pharmacy, Biochemistry, Pharmacology +17

Evaluation of the Safety, Tolerability, and Pharmacokinetic Profiles of TP0473292 (TS-161), A Prodrug of a Novel Orthosteric mGlu2/3 Receptor Antagonist TP0178894, in Healthy Subjects and Its Antidepressant-Like Effects in Rodents

Mai Watanabe, Brian Marcy, Ayano Hiroki et al. · The International Journal of Neuropsychopharmacology · 2021 · 20 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Impact of Reduced Renal Function on the Glucose-Lowering Effects of Luseogliflozin, a Selective SGLT2 Inhibitor, Assessed by Continuous Glucose Monitoring in Japanese Patients with Type 2 Diabetes Mellitus

Hideaki Jinnouchi, Kazunari Nozaki, Hirotaka Watase et al. · Advances in Therapy · 2016 · 16 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Novel Compound Induces Erythropoietin Secretion through Liver Effects in Chronic Kidney Disease Patients and Healthy Volunteers

Aya Shinfuku, Toshiharu Shimazaki, Masanori Fujiwara et al. · American Journal of Nephrology · 2018 · 14 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13